Kura Oncology, Inc. (KURA) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-22

Kura Oncology, Inc. (KURA) has filed 12 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-22. 2 Form 8-K material event filings were reported by KURA in the last 90 days. 5 Form 144 notices of proposed sale were filed for KURA stock. InsiderAlpha tracks every KURA SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Kura Oncology, Inc. (KURA)

SEC CIK0001422143

90-Day SEC Filing Activity

Form 4 filings (90d)12
Form 8-K filings (90d)2
Form 144 notices (90d)5
Latest Form 4 filing2026-06-22

Recent KURA Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
Leoni MollieChief Medical OfficerS — Open-market sale84.9K$9.82$834KSEC
Powl Brian T.Chief Commercial OfficerS — Open-market sale10.0K$11.00$110KSEC
FORD KATHLEENChief Operating OfficerS — Open-market sale2.3K$9.08$20KSEC
Powl Brian T.Chief Commercial OfficerS — Open-market sale339$9.21$3KSEC
Bair Teresa BrophyChief Legal OfficerS — Open-market sale2.3K$9.38$21KSEC
WILSON TROY EDWARDPresident and CEOM — Option exercise6.1K$6.15$38KSEC
Malley ThomasInsiderM — Option exercise10.0K$3.12$31KSEC
Burrows FrancisChief Scientific OfficerS — Open-market sale1.3K$8.46$11KSEC
DOYLE THOMAS JAMESSVP, Finance & AccountingS — Open-market sale1.1K$8.46$9KSEC
Bair Teresa BrophyChief Legal OfficerS — Open-market sale4.1K$8.46$35KSEC
Leoni MollieChief Medical OfficerS — Open-market sale2.2K$8.46$19KSEC
Leoni MollieChief Medical OfficerS — Open-market sale1.3K$8.46$11KSEC
Leoni MollieChief Medical OfficerS — Open-market sale3.7K$8.46$31KSEC
Leoni MollieChief Medical OfficerS — Open-market sale951$8.46$8KSEC
DOYLE THOMAS JAMESSVP, Finance & AccountingS — Open-market sale695$8.46$6KSEC

All transactions sourced from SEC EDGAR Form 4 filings for Kura Oncology, Inc. (KURA). Updated in real time as new filings are submitted to the SEC.

Most-Active KURA Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
Powl Brian T.2$113K
Szela Mary T1—
Leoni Mollie1$834K
FORD KATHLEEN1$20K
Malley Thomas1—

Recent KURA Form 8-K Material Events

Recent KURA Form 144 Notices of Proposed Sale

Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in KURA insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

KURA Insider Trading — FAQ

What is the latest insider trade for KURA?
Kura Oncology, Inc. (KURA) had 12 insider filings in the last 90 days, with the most recent on 2026-06-22. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying KURA stock?
0 insider purchases of KURA were filed in the last 90 days.
How many insiders are selling KURA stock?
0 insider sales of KURA were filed in the last 90 days.
Where can I see KURA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every KURA SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live KURA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.